======= SF3B5 ======= == Gene Information == * **Official Symbol**: SF3B5 * **Official Name**: splicing factor 3b subunit 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83443|83443]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BWJ5|Q9BWJ5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SF3B5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SF3B5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617847|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex (PubMed:27720643). SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). {ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:27720643}. |SF3b10| |U2 snRNP| |U12-type spliceosomal complex| |U2-type precatalytic spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions| |RNA splicing| |mRNA processing| |mRNA metabolic process| |RNA processing| |RNA binding| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp365|I-BRD9 4μM R07 exp365]]|1.7| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.7| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.71| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.72| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|1.77| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|1.91| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|2.19| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.455| |[[:human genes:g:gar1|GAR1]]|0.434| |[[:human genes:p:prim1|PRIM1]]|0.425| |[[:human genes:o:orc1|ORC1]]|0.416| |[[:human genes:t:tfip11|TFIP11]]|0.413| |[[:human genes:s:sf3a2|SF3A2]]|0.413| |[[:human genes:n:narfl|NARFL]]|0.408| |[[:human genes:o:orc6|ORC6]]|0.404| |[[:human genes:s:snrpa1|SNRPA1]]|0.402| |[[:human genes:c:copg1|COPG1]]|0.402| Global Fraction of Cell Lines Where Essential: 739/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1431 * **Expression level (log2 read counts)**: 5.34 {{:chemogenomics:nalm6 dist.png?nolink |}}